Literature DB >> 19627641

Cognitive/personality pattern and triplet expansion size in adult myotonic dystrophy type 1 (DM1): CTG repeats, cognition and personality in DM1.

A Sistiaga1, I Urreta, M Jodar, A M Cobo, J Emparanza, D Otaegui, J J Poza, J J Merino, H Imaz, J F Martí-Massó, A López de Munain.   

Abstract

BACKGROUND: Although central nervous system (CNS) involvement in adult myotonic dystrophy type 1 (DM1) was described long ago, the large number of variables affecting the cognitive and personality profile have made it difficult to determine the effect of DM1 on the brain. The aim of this study was to define the cognitive and personality patterns in adult DM1 patients, and to analyse the relationship between these clinical patterns and their association with the underlying molecular defect.
METHOD: We examined 121 adult DM1 patients with confirmed molecular CTG repeat expansion and 54 control subjects using comprehensive neuropsychological tests and personality assessments with the Millon Clinical Multiaxial Inventory (MCMI)-II. We used a multiple linear regression model to assess the effect of each variable on cognition and personality adjusted to the remainders.
RESULTS: Patients performed significantly worse than controls in tests measuring executive function (principally cognitive inflexibility) and visuoconstructive ability. In the personality profile, some paranoid and aggressive traits were predominant. Furthermore, there was a significant negative correlation between the CTG expansion size and many of the neuropsychological and personality measures. The molecular defect also correlated with patients' daytime somnolence.
CONCLUSIONS: Besides muscular symptomatology, there is significant CTG-dependent involvement of the CNS in adult DM1 patients. Our data indicate that the cognitive impairment predominantly affects the fronto-parietal lobe.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19627641     DOI: 10.1017/S0033291709990602

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  27 in total

1.  Genome modification leads to phenotype reversal in human myotonic dystrophy type 1 induced pluripotent stem cell-derived neural stem cells.

Authors:  Guangbin Xia; Yuanzheng Gao; Shouguang Jin; S H Subramony; Naohiro Terada; Laura P W Ranum; Maurice S Swanson; Tetsuo Ashizawa
Journal:  Stem Cells       Date:  2015-06       Impact factor: 6.277

2.  Myotonic dystrophy CTG expansion affects synaptic vesicle proteins, neurotransmission and mouse behaviour.

Authors:  Oscar Hernández-Hernández; Céline Guiraud-Dogan; Géraldine Sicot; Aline Huguet; Sabrina Luilier; Esther Steidl; Stefanie Saenger; Elodie Marciniak; Hélène Obriot; Caroline Chevarin; Annie Nicole; Lucile Revillod; Konstantinos Charizanis; Kuang-Yung Lee; Yasuhiro Suzuki; Takashi Kimura; Tohru Matsuura; Bulmaro Cisneros; Maurice S Swanson; Fabrice Trovero; Bruno Buisson; Jean-Charles Bizot; Michel Hamon; Sandrine Humez; Guillaume Bassez; Friedrich Metzger; Luc Buée; Arnold Munnich; Nicolas Sergeant; Geneviève Gourdon; Mário Gomes-Pereira
Journal:  Brain       Date:  2013-02-11       Impact factor: 13.501

3.  Generation of neural cells from DM1 induced pluripotent stem cells as cellular model for the study of central nervous system neuropathogenesis.

Authors:  Guangbin Xia; Katherine E Santostefano; Marianne Goodwin; Jilin Liu; S H Subramony; Maurice S Swanson; Naohiro Terada; Tetsuo Ashizawa
Journal:  Cell Reprogram       Date:  2013-04       Impact factor: 1.987

4.  Predicting daytime sleepiness and fatigue: a 9-year prospective study in myotonic dystrophy type 1.

Authors:  Luc Laberge; Benjamin Gallais; Julie Auclair; Yves Dauvilliers; Jean Mathieu; Cynthia Gagnon
Journal:  J Neurol       Date:  2019-10-31       Impact factor: 4.849

5.  Prevalence and correlates of apathy in myotonic dystrophy type 1.

Authors:  Benjamin Gallais; Michèle Montreuil; Marcela Gargiulo; Bruno Eymard; Cynthia Gagnon; Luc Laberge
Journal:  BMC Neurol       Date:  2015-08-22       Impact factor: 2.474

6.  Comparisons of intellectual capacities between mild and classic adult-onset phenotypes of myotonic dystrophy type 1 (DM1).

Authors:  Stéphane Jean; Louis Richer; Luc Laberge; Jean Mathieu
Journal:  Orphanet J Rare Dis       Date:  2014-11-26       Impact factor: 4.123

Review 7.  Muscle wasting in myotonic dystrophies: a model of premature aging.

Authors:  Alba Judith Mateos-Aierdi; Maria Goicoechea; Ana Aiastui; Roberto Fernández-Torrón; Mikel Garcia-Puga; Ander Matheu; Adolfo López de Munain
Journal:  Front Aging Neurosci       Date:  2015-07-09       Impact factor: 5.750

Review 8.  Therapeutic advances in muscular dystrophy.

Authors:  Doris G Leung; Kathryn R Wagner
Journal:  Ann Neurol       Date:  2013-09       Impact factor: 10.422

9.  "I Know that You Know that I Know": Neural Substrates Associated with Social Cognition Deficits in DM1 Patients.

Authors:  Laura Serra; Mara Cercignani; Michela Bruschini; Lisa Cipolotti; Matteo Mancini; Gabriella Silvestri; Antonio Petrucci; Elisabetta Bucci; Giovanni Antonini; Loretta Licchelli; Barbara Spanò; Manlio Giacanelli; Carlo Caltagirone; Giovanni Meola; Marco Bozzali
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

10.  Disease awareness in myotonic dystrophy type 1: an observational cross-sectional study.

Authors:  Sigrid Baldanzi; Francesca Bevilacqua; Rita Lorio; Leda Volpi; Costanza Simoncini; Antonio Petrucci; Mirco Cosottini; Gabriele Massimetti; Gloria Tognoni; Giulia Ricci; Corrado Angelini; Gabriele Siciliano
Journal:  Orphanet J Rare Dis       Date:  2016-04-04       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.